Menu Search
Equities

Lytix Biopharma AS

LYTIX:OSL

Lytix Biopharma AS

Actions
  • Price (NOK)7.88
  • Today's Change0.34 / 4.51%
  • Shares traded89.06k
  • 1 Year change+5.24%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Lytix Biopharma AS share price to rise to 16.00 in the next year from the last price of 7.88.
High103.0%16.00
Med103.0%16.00
Low103.0%16.00

Earnings history & estimates in NOK

While analysts are not providing 2nd quarter earnings estimates for Lytix Biopharma AS, they are predicting full year 2024 losses of -77.00 per share. On Aug 29, 2024, Lytix Biopharma AS reported 2nd quarter 2024 losses of -- per share.
Average growth rate-2.01%
Lytix Biopharma AS reported annual 2023 losses of -2.16 per share on Feb 28, 2024.
More ▼

Revenue history & estimates in NOK

Lytix Biopharma AS had revenues for the full year 2023 of 3.99m. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.